Copyright Reports & Markets. All rights reserved.

Global Equine Drugs and Supplement Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032

Request for Sample of this report
Buy now

1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Market Analysis by Type
    • 1.3.1 Overview: Global Equine Drugs and Supplement Consumption Value by Type: 2021 Versus 2025 Versus 2032
    • 1.3.2 Supplements
    • 1.3.3 Pharmaceutical Drugs
  • 1.4 Market Analysis by Application
    • 1.4.1 Overview: Global Equine Drugs and Supplement Consumption Value by Application: 2021 Versus 2025 Versus 2032
    • 1.4.2 Drugstores
    • 1.4.3 Veterinary Hospitals
    • 1.4.4 Others
  • 1.5 Global Equine Drugs and Supplement Market Size & Forecast
    • 1.5.1 Global Equine Drugs and Supplement Consumption Value (2021 & 2025 & 2032)
    • 1.5.2 Global Equine Drugs and Supplement Sales Quantity (2021-2032)
    • 1.5.3 Global Equine Drugs and Supplement Average Price (2021-2032)

2 Manufacturers Profiles

  • 2.1 Bayer Animal Health
    • 2.1.1 Bayer Animal Health Details
    • 2.1.2 Bayer Animal Health Major Business
    • 2.1.3 Bayer Animal Health Equine Drugs and Supplement Product and Services
    • 2.1.4 Bayer Animal Health Equine Drugs and Supplement Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.1.5 Bayer Animal Health Recent Developments/Updates
  • 2.2 Boehringer Ingelheim
    • 2.2.1 Boehringer Ingelheim Details
    • 2.2.2 Boehringer Ingelheim Major Business
    • 2.2.3 Boehringer Ingelheim Equine Drugs and Supplement Product and Services
    • 2.2.4 Boehringer Ingelheim Equine Drugs and Supplement Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.2.5 Boehringer Ingelheim Recent Developments/Updates
  • 2.3 Elanco (Eli Lilly)
    • 2.3.1 Elanco (Eli Lilly) Details
    • 2.3.2 Elanco (Eli Lilly) Major Business
    • 2.3.3 Elanco (Eli Lilly) Equine Drugs and Supplement Product and Services
    • 2.3.4 Elanco (Eli Lilly) Equine Drugs and Supplement Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.3.5 Elanco (Eli Lilly) Recent Developments/Updates
  • 2.4 Merck Animal Health
    • 2.4.1 Merck Animal Health Details
    • 2.4.2 Merck Animal Health Major Business
    • 2.4.3 Merck Animal Health Equine Drugs and Supplement Product and Services
    • 2.4.4 Merck Animal Health Equine Drugs and Supplement Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.4.5 Merck Animal Health Recent Developments/Updates
  • 2.5 Merial
    • 2.5.1 Merial Details
    • 2.5.2 Merial Major Business
    • 2.5.3 Merial Equine Drugs and Supplement Product and Services
    • 2.5.4 Merial Equine Drugs and Supplement Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.5.5 Merial Recent Developments/Updates
  • 2.6 Novartis Animal Health
    • 2.6.1 Novartis Animal Health Details
    • 2.6.2 Novartis Animal Health Major Business
    • 2.6.3 Novartis Animal Health Equine Drugs and Supplement Product and Services
    • 2.6.4 Novartis Animal Health Equine Drugs and Supplement Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.6.5 Novartis Animal Health Recent Developments/Updates
  • 2.7 Zoetis
    • 2.7.1 Zoetis Details
    • 2.7.2 Zoetis Major Business
    • 2.7.3 Zoetis Equine Drugs and Supplement Product and Services
    • 2.7.4 Zoetis Equine Drugs and Supplement Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.7.5 Zoetis Recent Developments/Updates

3 Competitive Environment: Equine Drugs and Supplement by Manufacturer

  • 3.1 Global Equine Drugs and Supplement Sales Quantity by Manufacturer (2021-2026)
  • 3.2 Global Equine Drugs and Supplement Revenue by Manufacturer (2021-2026)
  • 3.3 Global Equine Drugs and Supplement Average Price by Manufacturer (2021-2026)
  • 3.4 Market Share Analysis (2025)
    • 3.4.1 Producer Shipments of Equine Drugs and Supplement by Manufacturer Revenue ($MM) and Market Share (%): 2025
    • 3.4.2 Top 3 Equine Drugs and Supplement Manufacturer Market Share in 2025
    • 3.4.3 Top 6 Equine Drugs and Supplement Manufacturer Market Share in 2025
  • 3.5 Equine Drugs and Supplement Market: Overall Company Footprint Analysis
    • 3.5.1 Equine Drugs and Supplement Market: Region Footprint
    • 3.5.2 Equine Drugs and Supplement Market: Company Product Type Footprint
    • 3.5.3 Equine Drugs and Supplement Market: Company Product Application Footprint
  • 3.6 New Market Entrants and Barriers to Market Entry
  • 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

  • 4.1 Global Equine Drugs and Supplement Market Size by Region
    • 4.1.1 Global Equine Drugs and Supplement Sales Quantity by Region (2021-2032)
    • 4.1.2 Global Equine Drugs and Supplement Consumption Value by Region (2021-2032)
    • 4.1.3 Global Equine Drugs and Supplement Average Price by Region (2021-2032)
  • 4.2 North America Equine Drugs and Supplement Consumption Value (2021-2032)
  • 4.3 Europe Equine Drugs and Supplement Consumption Value (2021-2032)
  • 4.4 Asia-Pacific Equine Drugs and Supplement Consumption Value (2021-2032)
  • 4.5 South America Equine Drugs and Supplement Consumption Value (2021-2032)
  • 4.6 Middle East & Africa Equine Drugs and Supplement Consumption Value (2021-2032)

5 Market Segment by Type

  • 5.1 Global Equine Drugs and Supplement Sales Quantity by Type (2021-2032)
  • 5.2 Global Equine Drugs and Supplement Consumption Value by Type (2021-2032)
  • 5.3 Global Equine Drugs and Supplement Average Price by Type (2021-2032)

6 Market Segment by Application

  • 6.1 Global Equine Drugs and Supplement Sales Quantity by Application (2021-2032)
  • 6.2 Global Equine Drugs and Supplement Consumption Value by Application (2021-2032)
  • 6.3 Global Equine Drugs and Supplement Average Price by Application (2021-2032)

7 North America

  • 7.1 North America Equine Drugs and Supplement Sales Quantity by Type (2021-2032)
  • 7.2 North America Equine Drugs and Supplement Sales Quantity by Application (2021-2032)
  • 7.3 North America Equine Drugs and Supplement Market Size by Country
    • 7.3.1 North America Equine Drugs and Supplement Sales Quantity by Country (2021-2032)
    • 7.3.2 North America Equine Drugs and Supplement Consumption Value by Country (2021-2032)
    • 7.3.3 United States Market Size and Forecast (2021-2032)
    • 7.3.4 Canada Market Size and Forecast (2021-2032)
    • 7.3.5 Mexico Market Size and Forecast (2021-2032)

8 Europe

  • 8.1 Europe Equine Drugs and Supplement Sales Quantity by Type (2021-2032)
  • 8.2 Europe Equine Drugs and Supplement Sales Quantity by Application (2021-2032)
  • 8.3 Europe Equine Drugs and Supplement Market Size by Country
    • 8.3.1 Europe Equine Drugs and Supplement Sales Quantity by Country (2021-2032)
    • 8.3.2 Europe Equine Drugs and Supplement Consumption Value by Country (2021-2032)
    • 8.3.3 Germany Market Size and Forecast (2021-2032)
    • 8.3.4 France Market Size and Forecast (2021-2032)
    • 8.3.5 United Kingdom Market Size and Forecast (2021-2032)
    • 8.3.6 Russia Market Size and Forecast (2021-2032)
    • 8.3.7 Italy Market Size and Forecast (2021-2032)

9 Asia-Pacific

  • 9.1 Asia-Pacific Equine Drugs and Supplement Sales Quantity by Type (2021-2032)
  • 9.2 Asia-Pacific Equine Drugs and Supplement Sales Quantity by Application (2021-2032)
  • 9.3 Asia-Pacific Equine Drugs and Supplement Market Size by Region
    • 9.3.1 Asia-Pacific Equine Drugs and Supplement Sales Quantity by Region (2021-2032)
    • 9.3.2 Asia-Pacific Equine Drugs and Supplement Consumption Value by Region (2021-2032)
    • 9.3.3 China Market Size and Forecast (2021-2032)
    • 9.3.4 Japan Market Size and Forecast (2021-2032)
    • 9.3.5 South Korea Market Size and Forecast (2021-2032)
    • 9.3.6 India Market Size and Forecast (2021-2032)
    • 9.3.7 Southeast Asia Market Size and Forecast (2021-2032)
    • 9.3.8 Australia Market Size and Forecast (2021-2032)

10 South America

  • 10.1 South America Equine Drugs and Supplement Sales Quantity by Type (2021-2032)
  • 10.2 South America Equine Drugs and Supplement Sales Quantity by Application (2021-2032)
  • 10.3 South America Equine Drugs and Supplement Market Size by Country
    • 10.3.1 South America Equine Drugs and Supplement Sales Quantity by Country (2021-2032)
    • 10.3.2 South America Equine Drugs and Supplement Consumption Value by Country (2021-2032)
    • 10.3.3 Brazil Market Size and Forecast (2021-2032)
    • 10.3.4 Argentina Market Size and Forecast (2021-2032)

11 Middle East & Africa

  • 11.1 Middle East & Africa Equine Drugs and Supplement Sales Quantity by Type (2021-2032)
  • 11.2 Middle East & Africa Equine Drugs and Supplement Sales Quantity by Application (2021-2032)
  • 11.3 Middle East & Africa Equine Drugs and Supplement Market Size by Country
    • 11.3.1 Middle East & Africa Equine Drugs and Supplement Sales Quantity by Country (2021-2032)
    • 11.3.2 Middle East & Africa Equine Drugs and Supplement Consumption Value by Country (2021-2032)
    • 11.3.3 Turkey Market Size and Forecast (2021-2032)
    • 11.3.4 Egypt Market Size and Forecast (2021-2032)
    • 11.3.5 Saudi Arabia Market Size and Forecast (2021-2032)
    • 11.3.6 South Africa Market Size and Forecast (2021-2032)

12 Market Dynamics

  • 12.1 Equine Drugs and Supplement Market Drivers
  • 12.2 Equine Drugs and Supplement Market Restraints
  • 12.3 Equine Drugs and Supplement Trends Analysis
  • 12.4 Porters Five Forces Analysis
    • 12.4.1 Threat of New Entrants
    • 12.4.2 Bargaining Power of Suppliers
    • 12.4.3 Bargaining Power of Buyers
    • 12.4.4 Threat of Substitutes
    • 12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain

  • 13.1 Raw Material of Equine Drugs and Supplement and Key Manufacturers
  • 13.2 Manufacturing Costs Percentage of Equine Drugs and Supplement
  • 13.3 Equine Drugs and Supplement Production Process
  • 13.4 Industry Value Chain Analysis

14 Shipments by Distribution Channel

  • 14.1 Sales Channel
    • 14.1.1 Direct to End-User
    • 14.1.2 Distributors
  • 14.2 Equine Drugs and Supplement Typical Distributors
  • 14.3 Equine Drugs and Supplement Typical Customers

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Methodology
    • 16.2 Research Process and Data Source

    According to our (Global Info Research) latest study, the global Equine Drugs and Supplement market size was valued at US$ million in 2025 and is forecast to a readjusted size of US$ million by 2032 with a CAGR of %during review period.
    The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
    This report is a detailed and comprehensive analysis for global Equine Drugs and Supplement market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
    Key Features:
    Global Equine Drugs and Supplement market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
    Global Equine Drugs and Supplement market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
    Global Equine Drugs and Supplement market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
    Global Equine Drugs and Supplement market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2021-2026
    The Primary Objectives in This Report Are:
    To determine the size of the total market opportunity of global and key countries
    To assess the growth potential for Equine Drugs and Supplement
    To forecast future growth in each product and end-use market
    To assess competitive factors affecting the marketplace
    This report profiles key players in the global Equine Drugs and Supplement market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Bayer Animal Health, Boehringer Ingelheim, Elanco (Eli Lilly), Merck Animal Health, Merial, Novartis Animal Health, Zoetis, etc.
    This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
    Market Segmentation
    Equine Drugs and Supplement market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
    Market segment by Type
    Supplements
    Pharmaceutical Drugs
    Market segment by Application
    Drugstores
    Veterinary Hospitals
    Others
    Major players covered
    Bayer Animal Health
    Boehringer Ingelheim
    Elanco (Eli Lilly)
    Merck Animal Health
    Merial
    Novartis Animal Health
    Zoetis
    Market segment by region, regional analysis covers
    North America (United States, Canada, and Mexico)
    Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
    South America (Brazil, Argentina, Colombia, and Rest of South America)
    Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
    The content of the study subjects, includes a total of 15 chapters:
    Chapter 1, to describe Equine Drugs and Supplement product scope, market overview, market estimation caveats and base year.
    Chapter 2, to profile the top manufacturers of Equine Drugs and Supplement, with price, sales quantity, revenue, and global market share of Equine Drugs and Supplement from 2021 to 2026.
    Chapter 3, the Equine Drugs and Supplement competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
    Chapter 4, the Equine Drugs and Supplement breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
    Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
    Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and Equine Drugs and Supplement market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
    Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
    Chapter 13, the key raw materials and key suppliers, and industry chain of Equine Drugs and Supplement.
    Chapter 14 and 15, to describe Equine Drugs and Supplement sales channel, distributors, customers, research findings and conclusion.

    Buy now